2025 Winner: Medical, Healthcare, and Pharmaceuticals
Rapid Detection Heart Failure markers
CardiAI, led by founder Dr. Anmol Kapoor and VP Research & Innovation Dr. Raja B. Singh, advances AI-powered, biomarker-driven cardiology.
Their precision diagnostics make cardiac testing faster, more accurate, and more accessible. The team has developed AI analysis of cardiac biomarkers, genomic/microbiome services, and point-of-care devices, including the BParo 24-hr ambulatory BP monitor and NT-proBNP testing for heart failure. By translating cutting-edge science into real care, they help deliver personalized, equitable cardiovascular health for Canadians and beyond.
